Conformis CEO: Getting A Knee Up (Mad Money, CNBC)
Conformis is not responsible for the contents or reliability of any third-party materials accessible on Conformis’s website, including embedded videos, audio recordings and images, or links to external websites or other third-party materials. The information contained in such third-party materials may not be accurate or current, and Conformis does not necessarily endorse the views expressed within them. Any third-party materials are provided for your convenience and information only.
Conformis and Stryker Execute Development, License and Distribution Agreements
Deal to Cover Patient-Specific Instrumentation Used in Knee Arthroplasty BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a medical technology
New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients
BILLERICA, Mass., April 23, 2019 (GLOBE NEWSWIRE) — Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit